Target
Glutaminase kidney isoform, mitochondrial
Ligand
BDBM405185
Substrate
n/a
Meas. Tech.
ChEMBL_2022793 (CHEMBL4676606)
IC50
14±n/a nM
Citation
 Soth, MJLe, KDi Francesco, MEHamilton, MMLiu, GBurke, JPCarroll, CLKovacs, JJBardenhagen, JPBristow, CACardozo, MCzako, Bde Stanchina, EFeng, NGarvey, JRGay, JPDo, MKGGreer, JHan, MHarris, AHerrera, ZHuang, SGiuliani, VJiang, YJohnson, SBJohnson, TAKang, ZLeonard, PGLiu, ZMcAfoos, TMiller, MMorlacchi, PMullinax, RAPalmer, WSPang, JRogers, NRudin, CMShepard, HESpencer, NDTheroff, JWu, QXu, AYau, JADraetta, GToniatti, CHeffernan, TPJones, P Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties. J Med Chem 63:12957-12977 (2020) [PubMed]  Article
Target
Name:
Glutaminase kidney isoform, mitochondrial
Synonyms:
GLS | GLS1 | GLSK_HUMAN | Glutaminase 1 | K-glutaminase | KIAA0838 | L-glutamine amidohydrolase
Type:
Protein
Mol. Mass.:
73471.89
Organism:
Homo sapiens (Human)
Description:
O94925
Residue:
669
Sequence:
MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGGGGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL
  
Inhibitor
Name:
BDBM405185
Synonyms:
N-(pyridin-2-ylmethyl)-1-[4-(6-{2-[3- (trifluoromethoxy)phenyl]acetamido} pyridazin-3-yl)butyl]-1H-1,2,3- triazole-4-carboxamide | US10344025, Example 529 | US11370786, Example 529
Type:
Small organic molecule
Emp. Form.:
C26H25F3N8O3
Mol. Mass.:
554.5237
SMILES:
FC(F)(F)Oc1cccc(CC(=O)Nc2ccc(CCCCn3cc(nn3)C(=O)NCc3ccccn3)nn2)c1
Structure:
Search PDB for entries with ligand similarity: